Positions

Selected Publications

Academic Article

Year Title Altmetric
2021 Conversion to permanent vascular access is associated with improved markers of hemodialysis efficacy in children: Pediatric nephrology research consortium study.  Clinical Nephrology.  96:270-280. 2021
2021 Safety and efficacy of sucroferric oxyhydroxide in pediatric patients with chronic kidney disease.  Pediatric Nephrology.  36:1233-1244. 2021
2020 Predictors of time to first cannulation for arteriovenous fistula in pediatric hemodialysis patients: Midwest Pediatric Nephrology Consortium study.  Pediatric Nephrology.  35:287-295. 2020
2019 Kidney support in children using an ultrafiltration device: A multicenter, retrospective study.  Clinical Journal of the American Society of Nephrology.  14:1432-1440. 2019
2019 Correction to: Predictors of patency for arteriovenous fistulae and grafts in pediatric hemodialysis patients (Pediatric Nephrology, (2019), 34, 2, (329-339), 10.1007/s00467-018-4082-4).  Pediatric Nephrology.  34:1483-1484. 2019
2019 Predictors of patency for arteriovenous fistulae and grafts in pediatric hemodialysis patients.  Pediatric Nephrology.  34:329-339. 2019
2018 Neutral pH and low–glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis.  Kidney International.  94:419-429. 2018
2018 Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease.  Pediatric Nephrology.  33:325-333. 2018
2017 Proteinuria and progression of pediatric chronic kidney disease: lessons from recent clinical studies.  Pediatric Nephrology.  32:743-751. 2017
2016 Smaller circuits for smaller patients: improving renal support therapy with Aquadex™.  Pediatric Nephrology.  31:853-860. 2016
2015 Progression of pediatric CKD of nonglomerular origin in the CKiD cohort.  Clinical Journal of the American Society of Nephrology.  10:571-577. 2015
2014 Expanding the phenotype of proteinuria in Dent disease. A case series.  Pediatric Nephrology.  29:2051-2054. 2014
2014 Uric acid and the kidney.  Pediatric Nephrology.  29:999-1008. 2014
2012 An open-label study to evaluate a single-dose of cinacalcet in pediatric dialysis subjects.  Pediatric Nephrology.  27:1953-1959. 2012
2008 IgA Nephropathy in children and adults: Comparison of histologic features and clinical outcomes.  Nephrology Dialysis Transplantation.  23:2537-2545. 2008
2006 Sodium modeling attenuates rises in whole-blood viscosity during chronic hemodialysis in children with large inter-dialytic weight gain.  Pediatric Nephrology.  21:1179-1184. 2006
2003 Stages of status epilepticus in the developing brain.  Epilepsy Research.  55:9-19. 2003

Principal Investigator On

Investigator On

  • Cure Glomerulonephropathy (CureGN): Integrative Proteomics & Metabolomics for Pediatric Glomerula Disease Biomarkers  awarded by NATIONWIDE CHILDREN'S HOSPITAL
  • Cure Glomerulonephropathy (CureGN): Integrative Proteomics & Metabolomics for Pediatric Glomerula Disease Biomarkers  awarded by NATIONWIDE CHILDREN'S HOSPITAL
  • Kidney Undergraduate Research Experience (KURE)  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
  • NGAL Usage In Determining AKI Risk in Critically Ill Children (GUIDANCE)  awarded by CHILDREN'S HOSPITAL MEDICAL CENTER (CINCINNATI)
  • Novel Therapies for Chronic Allograft Dysfunction in Children  awarded by CHILDREN'S HOSPITAL (BOSTON)
  • Phase 2 Study of Selective Cytopheretic Device for the Treatment of Pediatric Patients with Acute Kidney Injury  awarded by CINCINNATI CHILDREN'S HOSPITAL
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION
  • Private Grant  awarded by RETROPHIN, INC.
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC.
  • Private Grant  awarded by OCTAPHARMA - NEW
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY
  • Private Grant  awarded by OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC.
  • Private Grant  awarded by WATERMARK RESEARCH PARTNERS INC
  • Reaching Equity for Adults and CHildren in Transplant (REACH-TRANSPLANT  awarded by THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
  • The Genetic Contribution to Drug Induced Renal lnjury:The Drug Induced Renal Injury Consortium (DIRECT)  awarded by INTERNATIONAL SAE CONSORTIOUM, LTD
  • Viral Triggers of Alioimmunity and Autoimmunity in Pediatric Lung Transplantation  awarded by Washington University

    • Education And Training

  • American University of Beirut Medical Center, Internship
  • American University of Beirut Medical Center, Residency
  • Cook County Hospital, Residency
  • Children's Memorial Hospital, Postdoctoral Fellowship
  • University of Texas Southwestern Medical Center, Postdoctoral Fellowship
  • Doctor of Medicine, 2008

    • Full Name

  • Sahar Fathallah-Shaykh